HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Electronic Letters to:

Original Article: E. T Schroeder, Ling Zheng, Kevin E Yarasheski, Dajun Qian, Yolanda Stewart, Carla Flores, Carmen Martinez, Michael Terk, and Fred R Sattler Treatment with Oxandrolone and the Durability of Effects in Older Men J Appl Physiol 2003; 0: 8082003 [Abstract] [PDF]

eLetters: Submit a response to this article

Electronic letters published:

Hypogonadism

Nelson Vergel, Stephanie Fulton, Thomas L. Wilding, and Frances Groen.   (27 February 2009)

Hypogonadism 27 February 2009
Nelson Vergel, wellness non profit director , Stephanie Fulton, Thomas L. Wilding, and Frances Groen. Send letter to journal: Re: Hypogonadism powertx{at}aol.com Nelson Vergel, et al.	It is unfortunate that these study did not provide a background of testosterone (in the form of a gel) to counteract the hypogonadism caused by the use of Oxandrolone which can account for the loss of LBM after cessation. Hypogonadism induced by androgens can last for many weeks after cessation and is responsible for loss of most of the lean body mass gained through androgen treatment. I am glad to see that the abdominal fat reductions were significant even after weeks of cessation. Thank you for this great study Nelson Vergel powerusa.org